6h6 143nd standard (fluidigm)
fluidigm is a verified supplier 
fluidigm manufactures this product 
93
Structured Review
fluidigm
6h6 143nd standard
6h6 143nd Standard, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/6h6+143nd+standard/Anti-Human+CD123%2FIL-3R+(6H6)-143Nd/pm39325623-241-65-60
Average 93 stars, based on 8 article reviews
6h6 143nd Standard, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/6h6+143nd+standard/Anti-Human+CD123%2FIL-3R+(6H6)-143Nd/pm39325623-241-65-60
Average 93 stars, based on 8 article reviews
6h6 143nd standard - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Functional Assay:Article Title: BTN2A1 targeting reprograms M2-like macrophages and TAMs via SYK and MAPK signaling. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Ovarian tumor 6 Discovery Life Science BTC1000-E1200000366050819MS Ovarian tumor 7 Discovery Life Science BTC1000-E1200000375061219MS Ovarian tumor 8 Discovery Life Science BTC1000-G2200003297071619MS Ovarian tumor 9 Discovery Life Science BTC1000-E1200005514080619MS Ovarian tumor 10 BioIVT 776718A1 Ovarian tumor 11 Atreide Biosamples 110875_01 Ovarian tumor 12 Atreide Biosamples 110876_01 Ovarian tumor 13 Atreide Biosamples 111307_1 Breast Tumor 1 BioIVT 776033A1 Breast Tumor 2 BioIVT 776040A1 Colorectal tumor 1 Discovery Life Science BTC1000-6F200019146021621MS Colorectal tumor 2 Discovery Life Science BTC1000-E1200011141091719MS Colorectal tumor 3 Discovery Life Science BTC1000-2B200018476110220MS Colorectal tumor 4 Discovery Life Science BTC1000-G2200005033050719MS Colorectal tumor 5 Discovery Life Science BTC1000-J7110002875080516MS Ovarian ascites CRCM/IPC GC-BIO N 01489 5 ColoRectal Cancer Liver metastasis Humanitas Clinical Hospital Not applicable Chemicals, peptides, and recombinant proteins Lanraplenib SelleckChem S9715 Mirdametinib (PD0325901) SelleckChem S1036 SP600125 Cell Signaling Technologies CST8177 Perm Buffer III BD BIOSCIENCES 558050 HEPES ThermoFisher Scientific 15630–080 UltraPure 1M Tris-HCl pH7.5 ThermoFisher Scientific 15567–027 Tween 20 Sigma Aldrich P1379-500ML NaCl Sigma Aldrich S5150-1L EDTA 0.5 M UltraPureTM ThermoFisher Scientific 15575–020 IGEPAL CA-630 (NP-40) Sigma Aldrich I8896 Glycerol Sigma Aldrich G5516-1L NaF (Sodium fluoride) Sigma Aldrich 215309-10G b-Glycerophosphate disodium salt hydrate Sigma Aldrich G9422-10G EGTA 0.5M pH 8.0 Alfa Aesar J61721.AD Sodium orthovanadate (Vanadate) Sigma Aldrich 567540-5MG 10x Tris-Buffered Saline Biorad 170–6435 Laemmli Buffer Biorad 161–0747 10x Tris/Glycine/SDS (TGS) Biorad 161–0772 5X transfer buffer Biorad 10026938 b-Mercaptoethanol Euromedex 4227-A ECLTM Blocking Agent GE Healthcare RPN2125V Precision Plus ProteinTM Dual Color Standards Biorad 161–0374 NuPAGETM 4–12% Bis–tris acrylamide gels ThermoFisher Scientific NP0322BOX PROTEAN TGXTM Precast Protein PolyAcrylamide Gels (midi or mini gel) Biorad 5678082–5678085-4561036 – 4561094 Ethanol 100% Service-Related Items 1.00983.9950 Bovine Serum Albumin (BSA) Euromedex 04-100-812-E Iodoacétamide Sigma Aldrich I1149-25G Recombinant human BTN2A1-6His Imcheck Therapeutics Not applicable Recombinant human BTN2A2-6His Imcheck Therapeutics Not applicable (Continued on next page) 22 Cell Reports 43, 114773, October 22, 2024 Article ll OPEN ACCESS Purification:Article Title: BTN2A1 targeting reprograms M2-like macrophages and TAMs via SYK and MAPK signaling. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Ovarian tumor 6 Discovery Life Science BTC1000-E1200000366050819MS Ovarian tumor 7 Discovery Life Science BTC1000-E1200000375061219MS Ovarian tumor 8 Discovery Life Science BTC1000-G2200003297071619MS Ovarian tumor 9 Discovery Life Science BTC1000-E1200005514080619MS Ovarian tumor 10 BioIVT 776718A1 Ovarian tumor 11 Atreide Biosamples 110875_01 Ovarian tumor 12 Atreide Biosamples 110876_01 Ovarian tumor 13 Atreide Biosamples 111307_1 Breast Tumor 1 BioIVT 776033A1 Breast Tumor 2 BioIVT 776040A1 Colorectal tumor 1 Discovery Life Science BTC1000-6F200019146021621MS Colorectal tumor 2 Discovery Life Science BTC1000-E1200011141091719MS Colorectal tumor 3 Discovery Life Science BTC1000-2B200018476110220MS Colorectal tumor 4 Discovery Life Science BTC1000-G2200005033050719MS Colorectal tumor 5 Discovery Life Science BTC1000-J7110002875080516MS Ovarian ascites CRCM/IPC GC-BIO N 01489 5 ColoRectal Cancer Liver metastasis Humanitas Clinical Hospital Not applicable Chemicals, peptides, and recombinant proteins Lanraplenib SelleckChem S9715 Mirdametinib (PD0325901) SelleckChem S1036 SP600125 Cell Signaling Technologies CST8177 Perm Buffer III BD BIOSCIENCES 558050 HEPES ThermoFisher Scientific 15630–080 UltraPure 1M Tris-HCl pH7.5 ThermoFisher Scientific 15567–027 Tween 20 Sigma Aldrich P1379-500ML NaCl Sigma Aldrich S5150-1L EDTA 0.5 M UltraPureTM ThermoFisher Scientific 15575–020 IGEPAL CA-630 (NP-40) Sigma Aldrich I8896 Glycerol Sigma Aldrich G5516-1L NaF (Sodium fluoride) Sigma Aldrich 215309-10G b-Glycerophosphate disodium salt hydrate Sigma Aldrich G9422-10G EGTA 0.5M pH 8.0 Alfa Aesar J61721.AD Sodium orthovanadate (Vanadate) Sigma Aldrich 567540-5MG 10x Tris-Buffered Saline Biorad 170–6435 Laemmli Buffer Biorad 161–0747 10x Tris/Glycine/SDS (TGS) Biorad 161–0772 5X transfer buffer Biorad 10026938 b-Mercaptoethanol Euromedex 4227-A ECLTM Blocking Agent GE Healthcare RPN2125V Precision Plus ProteinTM Dual Color Standards Biorad 161–0374 NuPAGETM 4–12% Bis–tris acrylamide gels ThermoFisher Scientific NP0322BOX PROTEAN TGXTM Precast Protein PolyAcrylamide Gels (midi or mini gel) Biorad 5678082–5678085-4561036 – 4561094 Ethanol 100% Service-Related Items 1.00983.9950 Bovine Serum Albumin (BSA) Euromedex 04-100-812-E Iodoacétamide Sigma Aldrich I1149-25G Recombinant human BTN2A1-6His Imcheck Therapeutics Not applicable Recombinant human BTN2A2-6His Imcheck Therapeutics Not applicable (Continued on next page) 22 Cell Reports 43, 114773, October 22, 2024 Article ll OPEN ACCESS |